Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Residual cancer after neoadjuvant therapy predicts recurrence years later in men undergoing surgery for high-risk prostate cancer.

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).

An internal memo was sent from White House budget officials to the U.S. Department of Health and Human Services (HHS). It was dated April 10 and was obtained by CNN.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

(HealthDay News) — Adverse pregnancy outcomes (APOs) mediate a small proportion of the association between prepregnancy obesity and cardiovascular disease (CVD) risk in midlife, according to a study ...

Prostate cancer and azoospermia/oligospermia risks were higher among male relatives of women with primary ovarian insufficiency.

(HealthDay News) — Overall cancer mortality rates declined from 2001 through 2022, while cancer incidence rates decreased from 2001 through 2013 and stabilized through 2021, according to the 2024 ...

A nephrologist argues that advancing kidney care in the US requires tailored guidelines addressing ethnic diversity & ...

More than 150 million Americans might lose no-cost access to these and other preventive care services under a case being heard Monday at the U.S. Supreme Court.